Test Price
2,800 AED✅ Home Collection Available
RGS9BP Gene Bradyopsia Genetic Test in Dubai | AED 2800 | NGS Sequencing
Executive Summary & Core Metrics
✅ Accuracy Guarantee: 99.9% diagnostic sensitivity through ISO-accredited NGS processing, fully aligned with DHA genetic testing standards.
🚑 Premium Logistics: VIP mobile phlebotomy with temperature-controlled cold-chain home collection, available daily from 8 AM to 11 PM. Blood draw or FTA card submission.
📞 Clinical Guidance: Complimentary telephonic post-test counselling by our DHA-credentialed genetics team to explain results and next steps.
💳 Insurance Verification: Direct billing check via WhatsApp: +971 54 548 8731
Test Overview & Methodology
This targeted genetic test uses Next Generation Sequencing (NGS) to detect pathogenic variants in the RGS9BP gene, the primary cause of bradyopsia — a rare cone dysfunction syndrome characterised by prolonged light adaptation and reduced dynamic visual acuity. Full-gene coverage ensures detection of single nucleotide variants, small insertions/deletions, and splice-site mutations with high sensitivity and specificity.
| Feature | Our Test (DHA-Licensed) | Closest Alternative |
|---|---|---|
| Methodology | NGS – full RGS9BP gene coverage including introns and UTRs | Targeted panel or Sanger sequencing (partial) |
| Turnaround Time | 3‑4 weeks | 4‑8 weeks |
| Pre‑Test Genetic Counselling | Included – pedigree chart and informed consent session | Often extra cost |
| Sample Options | Whole blood (EDTA), extracted DNA, or one‑drop blood on FTA card | Blood only (venipuncture) |
Physician Insight & Safety Protocols
“Bradyopsia is often misdiagnosed as general night blindness or psychogenic visual disturbance. The RGS9BP genetic test provides the molecular proof needed to differentiate this distinct cone dysfunction, enabling tailored visual rehabilitation and sports performance adjustments. I strongly advise pairing this result with a full-field electroretinogram and a clinical genetics consultation to avoid misinterpretation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA License: 9294403
Advisory: Medication & Lifestyle Precautions
⚠ Medication Warning
Do not discontinue or alter any prescribed ophthalmic or systemic medication based solely on this genetic test. Always consult your treating physician before making any changes to your eye care regimen.
Exclusion Criteria & Emergency Red Flags
🔴 Safety Exclusion Criteria & Emergency Red Flags
- Acute ocular pain, sudden vision loss, or severe photophobia – seek immediate emergency eye care.
- Pregnancy is not an exclusion but genetic counselling must adapt to prenatal context; inform your physician.
- Test is not validated for asymptomatic children under 12 years without prior genetic counsellor approval.
- If taking blood‑thinners, notify the home phlebotomist for safe blood draw.
- A positive result may require confirmatory testing (ERG, full‑field sensitivity test) – do not self‑interpret.
Patient FAQ & Clinical Guidance
1. What is the RGS9BP gene test and who should consider it?
The RGS9BP genetic test identifies disease‑causing variants responsible for bradyopsia, offering a definitive molecular diagnosis for patients with prolonged light adaptation or reduced dynamic visual acuity. It is recommended for individuals with suspected cone dysfunction, abnormal ERG findings, a family history of bradyopsia, or for sports scientists evaluating dynamic vision in athletes. Ophthalmologists and medical researchers also use it to distinguish bradyopsia from other inherited retinal disorders.
2. How is the test performed and what is the turnaround time?
The test begins with a blood sample (whole blood, extracted DNA, or a single drop on an FTA card) collected via our ISO‑certified cold‑chain home phlebotomy service. Results are delivered within 3 to 4 weeks. Upon arrival at our DHA‑licensed laboratory (License 1143), NGS sequencing and bioinformatics analysis are completed under strict quality control. A mandatory pre‑test genetic counselling session ensures informed consent and pedigree documentation.
3. What are the risks, and is genetic counselling necessary?
This non‑invasive genetic test carries no physical risk beyond standard venipuncture or finger‑prick. However, because a positive result may have psychological and familial implications, mandatory pre‑ and post‑test genetic counselling is included. All health data is protected under UAE Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Complimentary telephonic guidance with a DHA‑credentialed counsellor is provided. Insurance verification is available via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
This test is performed under the regulatory framework of the Dubai Health Authority (DHA) and in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 regarding health information and communication technology. Patient consent and clinical responsibility follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. All genetic data is encrypted and stored on secure servers within the UAE.
Clinical & Logistical Metadata
| Test Name | RGS9BP Gene Bradyopsia Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card (dried blood spot) |
| Methodology Used | Next Generation Sequencing (NGS) – full gene coverage |
| ICD-10-CM Code | H53.8 – Other visual disturbances (bradyopsia) |
| LOINC Code | 94900-7 – Genetic analysis of gene sequence (RGS9BP) |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians